| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27241-207-30 | 27241-207 | HUMAN PRESCRIPTION DRUG | Brexpiprazole | Brexpiprazole | TABLET | ORAL | 20230203 | N/A | ANDA | ANDA213718 | Ajanta Pharma USA Inc. | BREXPIPRAZOLE | 2 mg/1 | 30 TABLET in 1 BOTTLE (27241-207-30) |
| 27241-206-30 | 27241-206 | HUMAN PRESCRIPTION DRUG | Brexpiprazole | Brexpiprazole | TABLET | ORAL | 20230203 | N/A | ANDA | ANDA213718 | Ajanta Pharma USA Inc. | BREXPIPRAZOLE | 1 mg/1 | 30 TABLET in 1 BOTTLE (27241-206-30) |
| 27241-204-30 | 27241-204 | HUMAN PRESCRIPTION DRUG | Brexpiprazole | Brexpiprazole | TABLET | ORAL | 20230203 | N/A | ANDA | ANDA213718 | Ajanta Pharma USA Inc. | BREXPIPRAZOLE | .25 mg/1 | 30 TABLET in 1 BOTTLE (27241-204-30) |
| 27241-208-30 | 27241-208 | HUMAN PRESCRIPTION DRUG | Brexpiprazole | Brexpiprazole | TABLET | ORAL | 20230203 | N/A | ANDA | ANDA213718 | Ajanta Pharma USA Inc. | BREXPIPRAZOLE | 3 mg/1 | 30 TABLET in 1 BOTTLE (27241-208-30) |
| 27241-205-30 | 27241-205 | HUMAN PRESCRIPTION DRUG | Brexpiprazole | Brexpiprazole | TABLET | ORAL | 20230203 | N/A | ANDA | ANDA213718 | Ajanta Pharma USA Inc. | BREXPIPRAZOLE | .5 mg/1 | 30 TABLET in 1 BOTTLE (27241-205-30) |
| 27241-209-30 | 27241-209 | HUMAN PRESCRIPTION DRUG | Brexpiprazole | Brexpiprazole | TABLET | ORAL | 20230203 | N/A | ANDA | ANDA213718 | Ajanta Pharma USA Inc. | BREXPIPRAZOLE | 4 mg/1 | 30 TABLET in 1 BOTTLE (27241-209-30) |